Intestinal and hepatic microsomal metabolism of testosterone and progesterone by a 3 alpha-hydroxysteroid dehydrogenase to the 3 alpha-hydroxy derivatives in the channel catfish, Ictalurus punctatus.
Zhen Lou, Jodie V Johnson, Margaret O James
Index: J. Steroid Biochem. Mol. Biol. 82(4-5) , 413-24, (2002)
Full Text: HTML
Abstract
Intestinal or hepatic microsomes from channel catfish converted [4-14C]-testosterone to three major metabolites: 6 beta-hydroxytestosterone, androstenedione and a third metabolite. Formation of the unknown metabolite required NADPH as cofactor. When incubated with 200 microM testosterone, the rate of formation of the unknown metabolite was 265+/-158 pmol/(min mg) protein (mean+/-S.D.) in microsomes from the proximal intestine, 515+/-93 pmol/(min mg) protein in distal intestine and 226+/-42 pmol/(min mg) protein in hepatic microsomes. Comparison of the chromatographic and spectral properties of the unknown metabolite with those of authentic testosterone derivatives showed that this metabolite corresponded to 4-androstene-3 alpha,17 beta-diol. No 3 alpha-reduced metabolite was formed in incubations of testosterone with catfish intestinal cytosol. Testosterone was reduced to 5 alpha-dihydrotestosterone primarily in the cytosolic fraction and not in microsomes. Incubation of progesterone with intestinal microsomes resulted in the formation of a metabolite with properties similar to that of the 3 alpha-reduced testosterone, and this metabolite was identified by co-chromatography with authentic standard as 3 alpha-reduced progesterone. Thus, 3 alpha-hydroxysteroid dehydrogenase is an important pathway in intestinal microsomes of the channel catfish.
Related Compounds
Related Articles:
2010-01-01
[J. Pediatr. Endocrinol. Metab. 23(1-2) , 143-52, (2010)]
2003-10-01
[Pharm. Res. 20(10) , 1591-4, (2003)]
The use of heat treatment to eliminate drug interactions due to grapefruit juice.
2006-11-01
[Biol. Pharm. Bull. 29(11) , 2274-8, (2006)]
2006-06-01
[Drug Metab. Dispos. 34(6) , 950-4, (2006)]
The inhibitory effect of intestinal bacterial metabolite of ginsenosides on CYP3A activity.
2004-10-01
[Biol. Pharm. Bull. 27(10) , 1555-60, (2004)]